Tech Company Financing Transactions
Antipodean Pharmaceuticals Funding Round
5AM Ventures and Versant Ventures joined a $3 million venture round for Antipodean Pharmaceuticals. The round closed on 12/31/2007.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$2,980,000
Round
Undisclosed
Investors
5AM Ventures (John Diekman)
Versant Ventures (Bradley Bolzon)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
PO Box 776
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Undisclosed
Website
Email Address
Overview
Antipodean Pharmaceuticals,Inc is a creator of pharmaceuticals for antioxidant therapy, anti aging and rejuvenation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Gary Lane
Chief Executive Officer
Gregory Macpherson
Browse more venture capital transactions:
Prev: 12/31/2007: Decision Biomarkers venture capital transaction
Next: 12/31/2007: PodTech Network venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs